These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32239396)

  • 21. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
    Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
    Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mechanism of diabetic vascular endothelial dysfunction: Hypoadiponectinemia-induced NLRP3 inflammasome activation.
    Zhang J; Xia L; Zhang F; Zhu D; Xin C; Wang H; Zhang F; Guo X; Lee Y; Zhang L; Wang S; Guo X; Huang C; Gao F; Liu Y; Tao L
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1556-1567. PubMed ID: 28216285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice.
    Qu J; Yuan Z; Wang G; Wang X; Li K
    Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway.
    Wang A; Zhong G; Ying M; Fang Z; Chen Y; Wang H; Wang C; Liu C; Guo Y
    Neuropharmacology; 2024 Oct; 257():110063. PubMed ID: 38972372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NLRP3 regulates alveolar bone loss in ligature-induced periodontitis by promoting osteoclastic differentiation.
    Chen Y; Yang Q; Lv C; Chen Y; Zhao W; Li W; Chen H; Wang H; Sun W; Yuan H
    Cell Prolif; 2021 Feb; 54(2):e12973. PubMed ID: 33382502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model.
    He W; Long T; Pan Q; Zhang S; Zhang Y; Zhang D; Qin G; Chen L; Zhou J
    J Neuroinflammation; 2019 Apr; 16(1):78. PubMed ID: 30971286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRP3 inflammasome contributes to endothelial dysfunction in angiotensin II-induced hypertension in mice.
    Li X; Zhang Z; Luo M; Cheng Z; Wang R; Liu Q; Lv D; Yan J; Shang F; Luo S; Xia Y
    Microvasc Res; 2022 Sep; 143():104384. PubMed ID: 35618036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence against a role for NLRP3-driven islet inflammation in db/db mice.
    Kammoun HL; Allen TL; Henstridge DC; Barre S; Coll RC; Lancaster GI; Cron L; Reibe S; Chan JY; Bensellam M; Laybutt DR; Butler MS; Robertson AAB; O'Neill LA; Cooper MA; Febbraio MA
    Mol Metab; 2018 Apr; 10():66-73. PubMed ID: 29478918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18.
    Zhong WJ; Duan JX; Liu T; Yang HH; Guan XX; Zhang CY; Yang JT; Xiong JB; Zhou Y; Guan CX; Li Q
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107045. PubMed ID: 33045564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
    Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
    J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.
    Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M
    PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of NLRP3 inflammasome alleviates cognitive deficits in a mouse model of anti-NMDAR encephalitis induced by active immunization.
    Yang X; Sun A; Kong L; Yang X; Zhao X; Wang S
    Int Immunopharmacol; 2024 Aug; 137():112374. PubMed ID: 38851162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MCC950 closes the active conformation of NLRP3 to an inactive state.
    Tapia-Abellán A; Angosto-Bazarra D; Martínez-Banaclocha H; de Torre-Minguela C; Cerón-Carrasco JP; Pérez-Sánchez H; Arostegui JI; Pelegrin P
    Nat Chem Biol; 2019 Jun; 15(6):560-564. PubMed ID: 31086329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trophoblastic mitochondrial DNA induces endothelial dysfunction and NLRP3 inflammasome activation: Implications for preeclampsia.
    Lv Z; Lv DY; Meng JY; Sha XY; Qian XY; Chen YS; Pan XY; Yu GY; Liu HS
    Int Immunopharmacol; 2023 Jan; 114():109523. PubMed ID: 36508916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo.
    Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y
    Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model.
    Zhang W; Ba G; Tang R; Li M; Lin H
    Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition.
    Coll RC; Hill JR; Day CJ; Zamoshnikova A; Boucher D; Massey NL; Chitty JL; Fraser JA; Jennings MP; Robertson AAB; Schroder K
    Nat Chem Biol; 2019 Jun; 15(6):556-559. PubMed ID: 31086327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome.
    Romacho T; Valencia I; Ramos-González M; Vallejo S; López-Esteban M; Lorenzo O; Cannata P; Romero A; San Hipólito-Luengo A; Gómez-Cerezo JF; Peiró C; Sánchez-Ferrer CF
    Sci Rep; 2020 Mar; 10(1):5386. PubMed ID: 32214150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.